NCT01042379 2026-03-13
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2 Recruiting
Clinical Trials
6 trialsNCT04703322 2026-03-04
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
Daiichi Sankyo
Phase 2 Active not recruiting
NCT02975700 2026-01-13
A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma
Daiichi Sankyo
Phase NA Completed
NCT04635111 2025-10-06
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIOâ„¢ (Pexidartinib) Treatment
Daiichi Sankyo
Recruiting
NCT04488822 2025-09-09
PLX3397
Daiichi Sankyo
Phase 3 Active not recruiting
NCT02584647 2025-03-21
PLX3397
Columbia University
Phase 1/2 Terminated